Publisher: DelveInsight
Category: Prescription Drugs

Prescription Drugs market research reports by DelveInsight

(642 reports matching your criteria)
    • Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032

      Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032 “Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Zunsemetinib (ATI-450) for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the Zunsemetinib ( ... Read More

    • Sonelokimab Emerging Drug Insight and Market Forecast – 2032

      Sonelokimab Emerging Drug Insight and Market Forecast – 2032 “Sonelokimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Sonelokimab for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the Sonelokimab for Hidradenitis Suppurativa in the ... Read More

    • TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032

      TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032 “TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TAVNEOS (Avacopan) for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the TAVNEOS (Avacopan) for Hid ... Read More

    • ASN002 (Gusacitinib) Emerging Drug Insight and Market Forecast – 2032

      ASN002 (Gusacitinib) Emerging Drug Insight and Market Forecast – 2032 “ASN002 (Gusacitinib) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ASN002 (Gusacitinib) for Hand Eczema (HE) in the 7MM. A detailed picture of the ASN002 (Gusacitinib) for Hand Ecz ... Read More

    • ADCETRIS Drug Insight and Market Forecast – 2032

      ADCETRIS Drug Insight and Market Forecast – 2032 “ADCETRIS Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ADCETRIS for Cutaneous T-cell lymphoma (CTCL) in the seven major markets. A detailed picture of the ADCETRIS for Cutaneous T-cell lymphoma in the 7MM, i.e ... Read More

    • TOCTINO Drug Insight and Market Forecast – 2032

      TOCTINO Drug Insight and Market Forecast – 2032 “TOCTINO Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TOCTINO for Hand Eczema (HE) in EU4 and the UK. A detailed picture of the TOCTINO for Hand Eczema in EU4 (Germany, France, Italy, and Spain) and the United K ... Read More

    • VITRAKVI Market Drug Insight and Market Forecast − 2032

      VITRAKVI Market Drug Insight and Market Forecast − 2032 “VITRAKVI Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VITRAKVI for Pancreatic Cancer in the seven major markets. A detailed picture of the VITRAKVI for pancreatic cancer in the 7MM, i.e., the Uni ... Read More

    • EUCRISA Market Drug Insight and Market Forecast − 2032

      EUCRISA Market Drug Insight and Market Forecast − 2032 “EUCRISA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EUCRISA for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the EUCRISA for atopic dermatitis in the 7MM, i.e., the Un ... Read More

    • VP-102 Emerging Drug Insight and Market Forecast – 2032

      VP-102 Emerging Drug Insight and Market Forecast – 2032 “VP-102 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VP-102 for Common Warts in the seven major markets. A detailed picture of the VP-102 for Common Warts in the 7MM, i.e., the United States, EU ... Read More

    • LYNPARZA Market Drug Insight and Market Forecast − 2032

      LYNPARZA Market Drug Insight and Market Forecast − 2032 “LYNPARZA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LYNPARZA for Pancreatic Cancer in the seven major markets. A detailed picture of the LYNPARZA for pancreatic cancer in the 7MM, i.e., the Uni ... Read More

    • ROZLYTREK Market Drug Insight and Market Forecast − 2032

      ROZLYTREK Market Drug Insight and Market Forecast − 2032 “ROZLYTREK Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ROZLYTREK for Pancreatic Cancer in the seven major markets. A detailed picture of the ROZLYTREK for pancreatic cancer in the 7MM, i.e., the ... Read More

    • VBP-245 Emerging Drug Insight and Market Forecast – 2032

      VBP-245 Emerging Drug Insight and Market Forecast – 2032 “VBP-245 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VBP-245 for Common Warts in the seven major markets. A detailed picture of the VBP-245 for Common Warts in the 7MM, i.e., the United States ... Read More

    • POTELIGEO Drug Insight and Market Forecast – 2032

      POTELIGEO Drug Insight and Market Forecast – 2032 “POTELIGEO Drug Insight and Market Forecast – 2032” report provides comprehensive insights about POTELIGEO for Cutaneous T-cell lymphoma (CTCL) in the seven major markets. A detailed picture of the POTELIGEO for Cutaneous T-cell lymphoma in the 7MM, ... Read More

    • CORECTIM Market Drug Insight and Market Forecast − 2032

      CORECTIM Market Drug Insight and Market Forecast − 2032 “CORECTIM Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CORECTIM for Atopic Dermatitis (AD) in Japan. A detailed picture of the CORECTIM for atopic dermatitis in Japan for the study period 2019 –20 ... Read More

    • CANDIN Emerging Drug Insight and Market Forecast – 2032

      CANDIN Emerging Drug Insight and Market Forecast – 2032 “CANDIN Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CANDIN for Common Warts in the seven major markets. A detailed picture of the CANDIN for Common Warts in the 7MM, i.e., the United States, EU ... Read More

    • DUPIXENT Market Drug Insight and Market Forecast − 2032

      DUPIXENT Market Drug Insight and Market Forecast − 2032 “DUPIXENT Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about DUPIXENT for Atopic Dermatitis (AD) in the seven major markets. A detailed picture of the DUPIXENT for atopic dermatitis in the 7MM, i.e., th ... Read More

    • KEYTRUDA Market Drug Insight and Market Forecast − 2032

      KEYTRUDA Market Drug Insight and Market Forecast − 2032 “KEYTRUDA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about KEYTRUDA for Pancreatic Cancer in the seven major markets. A detailed picture of the KEYTRUDA for pancreatic cancer in the 7MM, i.e., the Uni ... Read More

    • AFINITOR Drug Insight and Market Forecast – 2032

      AFINITOR Drug Insight and Market Forecast – 2032 “AFINITOR Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AFINITOR for ER +ve HER2-ve Breast Cancer in the United States. A detailed picture of the AFINITOR for ER+ve HER2-ve Breast Cancer in the United States for ... Read More

    • Olaparib ± bevacizumab Emerging Drug Insight and Market Forecast – 2032

      Olaparib ± bevacizumab Emerging Drug Insight and Market Forecast – 2032 “Olaparib ± bevacizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Olaparib ± bevacizumab for Metastatic Colorectal Cancer in the 7MM. A detailed picture of the Olaparib ± beva ... Read More

    • ZEPOSIA Market Drug Insight and Market Forecast − 2032

      ZEPOSIA Market Drug Insight and Market Forecast − 2032 “ZEPOSIA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ZEPOSIA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the ZEPOSIA for ulcerative colitis in the 7MM, i.e., the ... Read More

    • LUCENTIS Market Drug Insight and Market Forecast − 2032

      LUCENTIS Market Drug Insight and Market Forecast − 2032 “LUCENTIS Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LUCENTIS for Diabetic Retinopathy in the seven major markets. A detailed picture of the LUCENTIS for diabetic retinopathy in the 7MM, i.e., t ... Read More

    • XELJANZ Market Drug Insight and Market Forecast − 2032

      XELJANZ Market Drug Insight and Market Forecast − 2032 “XELJANZ Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XELJANZ for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the XELJANZ for ulcerative colitis in the 7MM, i.e., the ... Read More

    • Orenitram Drug Insight and Market Forecast – 2032

      Orenitram Drug Insight and Market Forecast – 2032 “Orenitram Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Orenitram for Pulmonary Arterial Hypertension in the United States. A detailed picture of the Orenitram for Pulmonary Arterial Hypertension in the United ... Read More

    • ANJESO Drug Insight and Market Forecast – 2032

      ANJESO Drug Insight and Market Forecast – 2032 “ANJESO Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ANJESO for Postoperative Pain in the United States. A detailed picture of the ANJESO for Postoperative Pain in the United States for the study period 2019–2032 ... Read More

    • Iptacopan Emerging Drug Insight and Market Forecast – 2032

      Iptacopan Emerging Drug Insight and Market Forecast – 2032 “Iptacopan Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Iptacopan for Atypical Hemolytic Uremic Syndrome in the 7MM. A detailed picture of the Iptacopan for Atypical Hemolytic Uremic Syndrome ... Read More

1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings